Decision making by primary care trusts prejudices patient survivalBMJ 2010; 340 doi: http://dx.doi.org/10.1136/bmj.c540 (Published 27 January 2010) Cite this as: BMJ 2010;340:c540
- Anne Gulland
A professor of oncology has called for radical reform of primary care trusts (PCTs), branding them “excessively bureaucratic” and prejudicial to patient survival.
Professor Jonathan Waxman, professor of oncology at Imperial College, London, was addressing a seminar organised by the Westminster Health Forum looking at the cancer reform strategy. He said that the variations between PCTs in the treatments and drugs they offered patients were too great and that decisions on drugs were “not made by experts,” including the National Institute for Health and Clinical Excellence (NICE).
He used the example of new renal drugs which were approved by the Food and Drug Administration in the United States within …
Log in using your username and password
Log in through your institution
Sign up for a free trial